Developer docs
API playgroundTry for free, no card

Search company profiles

Sphaira

Full company profile

uuid0002u98

Namestring
Sphaira
Legal namestring
Sphaira Inc.
Websiteurl
sphaira.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Sphaira Inc. is a privately held Physical AI company developing autonomous transport systems for the built environment, with its legal headquarters in Cambridge, Massachusetts and operational roots in Berlin, Germany. Its core product, Moby (the Mobile Protective Bubble System), is an autonomous platform designed to move patients within hospitals without continuous human intervention, and the company has coined the term 'intramobility' to describe automated human transport inside facilities as a new mobility category. Moby has been in continuous operational use at Charité - Universitätsmedizin Berlin for approximately 1.5 years and is currently undergoing FDA approval, with parallel clinical studies being run at Stanford Children's Hospital and a development agreement in place with Mayo Clinic.

The company's underlying technology stack combines autonomous navigation, perception, and protective enclosure engineering targeted specifically at intra-facility patient transport, rather than outdoor autonomous vehicles. Sphaira monetizes via enterprise hardware sales and likely associated services to large hospital systems, with reference customers in tertiary care (Charité, Mayo Clinic, Stanford Children's, University Hospital Schleswig-Holstein). Go-to-market is partnership-driven and regulatory-gated: the company relies on development agreements, pilots, and clinical studies with marquee healthcare institutions to build validation, and is pursuing FDA clearance as the gating milestone for US commercialization. Airports are identified as a secondary long-term vertical. Capital backing to date consists of a $2.2M investment from Investitionsbank Berlin in September 2022 and program support from Endless Frontier Labs and NVIDIA Inception.

Operationally, Sphaira is a very early-stage company with 1-10 disclosed employees, no public revenue, and a single deployed product in limited use. The investment-relevant evidence base is thin: there are no disclosed headcount growth trends, no published patents, no named management team beyond founder/CEO Janis Münch, and no cap-table detail. The strategic trajectory hinges on FDA clearance for Moby and conversion of clinical-study and development-agreement relationships at Mayo Clinic and Stanford into paid deployments, with the Charité Berlin site continuing to function as the primary operational reference.

Short descriptiontext

Sphaira Inc. is a Physical AI company building the Moby autonomous mobile protective bubble system for patient transport inside hospitals, with deployment at Charité Berlin and ongoing clinical studies at Mayo Clinic and Stanford Children's Hospital ahead of FDA clearance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
autonomous patient transport, healthcare robotics, hospital logistics automation, physical AI mobility, intramobility technology
Industry1 code
PRIMARYHLAHAMAE
Patient Lifts, Transfer & Safe Handling Equipment (Hoists, Slings, Transfer Boards)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Autonomous Patient Transport Systems
TypeHardware Sales
Description

Revenue likely generated through sale or lease of autonomous transport robots and associated software/subscription services to healthcare systems. The technology replaces human transporters, creating operational cost savings that can offset system costs.

therobotreport.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Brand1 record
1Moby
Description

Mobile protective bubble system for autonomous patient transport. Undergoing FDA approval. In clinical use at Charité Berlin and undergoing clinical study at Stanford Children's Hospital.

therobotreport.com
Core offering1 text field

Sphaira develops and sells the Moby (Mobile Protective Bubble System), an autonomous Physical AI system that transports patients within hospitals without continuous human intervention. The product is designed to replace two to three human patient transporters per unit and is deployed at Charité Berlin (1.5 years operational use), with development agreements at Mayo Clinic and clinical studies at Stanford Children's Hospital, while pursuing FDA approval for US commercialization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 200-300% efficiency increase in hospital patient transport operations
+1 more record
Product overview1 text field

Sphaira offers a single core product platform called Moby (Mobile Protective Bubble System) for autonomous patient transport. The product is a Physical AI system that automates human transport within hospitals, designed to work alongside clinical staff to move patients autonomously. The company is currently focused on FDA approval for the Moby system while operating pilot programs with leading healthcare institutions including Charité Berlin, Mayo Clinic, and Stanford Children's Hospital.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sphaira has an ongoing collaboration with Charité Berlin, Europe's #1 hospital. Their Moby mobile protective bubble system has been in operational use at Charité for 1.5 years. This partnership serves as a primary reference customer and validation site for Sphaira's technology in a real hospital environment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sphaira announced a development agreement with Mayo Clinic for autonomous patient shuttles. This partnership involves collaborative product development and validation of Sphaira's transport technology in Mayo Clinic's healthcare environment.

3University Hospital Schleswig-Holstein
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Sphaira is in collaboration with University Hospital Schleswig-Holstein, a major German university hospital, as part of their healthcare partnership network for product development and validation.

sphaira.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

6 River Systems builds autonomous warehouse fulfillment robots; while not a hospital player, its mobile robotics platform and Shopify backing make it a relevant thematic comparable for autonomous-in-built-environments commercialization.

TypeDirect peer
Description

Diligent Robotics' Moxi robot performs autonomous hospital logistics tasks including supply delivery and patient support. It is the leading US-focused hospital service robot and competes directly with Sphaira for the same hospital automation budget.

TypeBroad incumbent
Description

Stryker is a major medical device incumbent with hospital capital equipment relationships and an emerging robotics portfolio. As a broad incumbent, it has the relationships and capital to enter autonomous hospital transport if the category scales.

TypeBroad incumbent
Description

Omnicell is a large, established healthcare automation vendor that acquired Aethon (TUG) and sells a broad portfolio of hospital pharmacy and supply-chain automation. It is the broad incumbent against which Sphaira must differentiate on patient-specific transport.

TypeEmerging player
Description

Locus Robotics is a leader in autonomous warehouse robots with adjacent technology stack (autonomous mobile manipulation) that could extend into healthcare logistics. Emerging comparable rather than a direct hospital competitor today.

TypeEmerging player
Description

MiR manufactures autonomous mobile robots for internal logistics in healthcare, manufacturing, and logistics. Its healthcare-focused deployments are an emerging overlap with Sphaira's hospital transport mission.

TypeDirect peer
Description

Vecna Robotics builds autonomous mobile robots for material handling in healthcare, warehousing, and manufacturing. Its healthcare logistics robots compete directly with Sphaira for hospital intra-facility transport workloads.

TypeDirect peer
Description

Relay Robotics develops autonomous service robots deployed in hospitals and hotels for delivery and patient-facing tasks. Same core technology stack (autonomous indoor mobile robots) and same hospital customer base as Sphaira.

TypeDirect peer
Description

Aethon's TUG autonomous mobile robots perform autonomous delivery and patient/material transport in hospitals, the most direct head-to-head competitor to Sphaira's Moby system. Both target the same clinical logistics use case and same buyer (hospital operations leadership).

TypeOthers
Description

Panasonic has invested in hospital and human-support robots (e.g., HSR platform) and supplies robotics components broadly. It is a thematically adjacent incumbent rather than a direct hospital-transport competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sphaira Inc. is a Physical AI company building the Moby autonomous mobile protective bubble system for patient transport inside hospitals, with deployment at Charité Berlin and ongoing clinical studies at Mayo Clinic and Stanford Children's Hospital ahead of FDA clearance.

What Sphaira does

Sphaira Inc. is a privately held Physical AI company developing autonomous transport systems for the built environment, with its legal headquarters in Cambridge, Massachusetts and operational roots in Berlin, Germany. Its core product, Moby (the Mobile Protective Bubble System), is an autonomous platform designed to move patients within hospitals without continuous human intervention, and the company has coined the term 'intramobility' to describe automated human transport inside facilities as a new mobility category. Moby has been in continuous operational use at Charité - Universitätsmedizin Berlin for approximately 1.5 years and is currently undergoing FDA approval, with parallel clinical studies being run at Stanford Children's Hospital and a development agreement in place with Mayo Clinic.

The company's underlying technology stack combines autonomous navigation, perception, and protective enclosure engineering targeted specifically at intra-facility patient transport, rather than outdoor autonomous vehicles. Sphaira monetizes via enterprise hardware sales and likely associated services to large hospital systems, with reference customers in tertiary care (Charité, Mayo Clinic, Stanford Children's, University Hospital Schleswig-Holstein). Go-to-market is partnership-driven and regulatory-gated: the company relies on development agreements, pilots, and clinical studies with marquee healthcare institutions to build validation, and is pursuing FDA clearance as the gating milestone for US commercialization. Airports are identified as a secondary long-term vertical. Capital backing to date consists of a $2.2M investment from Investitionsbank Berlin in September 2022 and program support from Endless Frontier Labs and NVIDIA Inception.

Operationally, Sphaira is a very early-stage company with 1-10 disclosed employees, no public revenue, and a single deployed product in limited use. The investment-relevant evidence base is thin: there are no disclosed headcount growth trends, no published patents, no named management team beyond founder/CEO Janis Münch, and no cap-table detail. The strategic trajectory hinges on FDA clearance for Moby and conversion of clinical-study and development-agreement relationships at Mayo Clinic and Stanford into paid deployments, with the Charité Berlin site continuing to function as the primary operational reference.

Sphaira firmographics

Firmographics
Name
Sphaira
Legal name
Sphaira Inc.
Website
https://sphaira.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Sphaira Inc. is a Physical AI company building the Moby autonomous mobile protective bubble system for patient transport inside hospitals, with deployment at Charité Berlin and ongoing clinical studies at Mayo Clinic and Stanford Children's Hospital ahead of FDA clearance.
Ownership category
akta.pro rank

Sphaira industry classification

Industry
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAMAE
Patient Lifts, Transfer & Safe Handling Equipment (Hoists, Slings, Transfer Boards)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)

Keywords

  • Autonomous patient transport
  • Healthcare robotics
  • Hospital logistics automation
  • Physical AI mobility
  • Intramobility technology

Where Sphaira is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sphaira business model

Business model

Revenue model

  1. Autonomous Patient Transport Systems: Revenue likely generated through sale or lease of autonomous transport robots and associated software/subscription services to healthcare systems. The technology replaces human transporters, creating operational cost savings that can offset system costs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Sphaira product offering

Product offering

Core offering

Sphaira develops and sells the Moby (Mobile Protective Bubble System), an autonomous Physical AI system that transports patients within hospitals without continuous human intervention. The product is designed to replace two to three human patient transporters per unit and is deployed at Charité Berlin (1.5 years operational use), with development agreements at Mayo Clinic and clinical studies at Stanford Children's Hospital, while pursuing FDA approval for US commercialization.

Product overview

Sphaira offers a single core product platform called Moby (Mobile Protective Bubble System) for autonomous patient transport. The product is a Physical AI system that automates human transport within hospitals, designed to work alongside clinical staff to move patients autonomously. The company is currently focused on FDA approval for the Moby system while operating pilot programs with leading healthcare institutions including Charité Berlin, Mayo Clinic, and Stanford Children's Hospital.

Differentiator

Problem solved

Functional benefit

Brands

  • Moby: Mobile protective bubble system for autonomous patient transport. Undergoing FDA approval. In clinical use at Charité Berlin and undergoing clinical study at Stanford Children's Hospital.

Quantifiable outcome

  • 200-300% efficiency increase in hospital patient transport operations
  • +1 more outcomes

Companies that use Sphaira

Customer profile

Named customers3 records

Segments2 records

Sphaira technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature2 records

Sphaira partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and major.

  • Charité BerlincoreStrategic or Co-development PartnerSphaira has an ongoing collaboration with Charité Berlin, Europe's #1 hospital. Their Moby mobile protective bubble system has been in operational use at Charité for 1.5 years. This partnership serves as a primary reference customer and validation site for Sphaira's technology in a real hospital environment.
  • Mayo CliniccoreStrategic or Co-development PartnerSphaira announced a development agreement with Mayo Clinic for autonomous patient shuttles. This partnership involves collaborative product development and validation of Sphaira's transport technology in Mayo Clinic's healthcare environment.
  • University Hospital Schleswig-HolsteinmajorStrategic or Co-development PartnerSphaira is in collaboration with University Hospital Schleswig-Holstein, a major German university hospital, as part of their healthcare partnership network for product development and validation.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Sphaira competitors and assessment

Company assessment

Others

  • 6 River Systems (Shopify): 6 River Systems builds autonomous warehouse fulfillment robots; while not a hospital player, its mobile robotics platform and Shopify backing make it a relevant thematic comparable for autonomous-in-built-environments commercialization.
  • Panasonic (hospital robotics / HSR): Panasonic has invested in hospital and human-support robots (e.g., HSR platform) and supplies robotics components broadly. It is a thematically adjacent incumbent rather than a direct hospital-transport competitor.

Direct peers

  • Diligent Robotics: Diligent Robotics' Moxi robot performs autonomous hospital logistics tasks including supply delivery and patient support. It is the leading US-focused hospital service robot and competes directly with Sphaira for the same hospital automation budget.
  • Vecna Robotics: Vecna Robotics builds autonomous mobile robots for material handling in healthcare, warehousing, and manufacturing. Its healthcare logistics robots compete directly with Sphaira for hospital intra-facility transport workloads.
  • Relay Robotics (formerly Savioke): Relay Robotics develops autonomous service robots deployed in hospitals and hotels for delivery and patient-facing tasks. Same core technology stack (autonomous indoor mobile robots) and same hospital customer base as Sphaira.
  • Aethon (TUG, part of Omnicell): Aethon's TUG autonomous mobile robots perform autonomous delivery and patient/material transport in hospitals, the most direct head-to-head competitor to Sphaira's Moby system. Both target the same clinical logistics use case and same buyer (hospital operations leadership).

Broad incumbents

  • Stryker (Mako / hospital equipment): Stryker is a major medical device incumbent with hospital capital equipment relationships and an emerging robotics portfolio. As a broad incumbent, it has the relationships and capital to enter autonomous hospital transport if the category scales.
  • Omnicell (parent of Aethon): Omnicell is a large, established healthcare automation vendor that acquired Aethon (TUG) and sells a broad portfolio of hospital pharmacy and supply-chain automation. It is the broad incumbent against which Sphaira must differentiate on patient-specific transport.

Emerging players

  • Locus Robotics: Locus Robotics is a leader in autonomous warehouse robots with adjacent technology stack (autonomous mobile manipulation) that could extend into healthcare logistics. Emerging comparable rather than a direct hospital competitor today.
  • Mobile Industrial Robots (MiR): MiR manufactures autonomous mobile robots for internal logistics in healthcare, manufacturing, and logistics. Its healthcare-focused deployments are an emerging overlap with Sphaira's hospital transport mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Sphaira financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sphaira leadership team

Management profile

Number of profiles

Sphaira funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sphaira M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sphaira

What does Sphaira do?

Sphaira develops and sells the Moby (Mobile Protective Bubble System), an autonomous Physical AI system that transports patients within hospitals without continuous human intervention. The product is designed to replace two to three human patient transporters per unit and is deployed at Charité Berlin (1.5 years operational use), with development agreements at Mayo Clinic and clinical studies at Stanford Children's Hospital, while pursuing FDA approval for US commercialization.

Is Sphaira a public or private company?

Sphaira is a private company. It is currently operating.

When was Sphaira founded?

Sphaira was founded in 2020. It employs 11 to 50 people.

Where is Sphaira based?

Sphaira is headquartered in Cambridge, United States, in the North America region.

How does Sphaira make money?

One revenue line is on record: autonomous Patient Transport Systems.

Who are Sphaira's main competitors?

Others on record are 6 River Systems (Shopify) and Panasonic (hospital robotics / HSR). Direct peers are Diligent Robotics, Vecna Robotics, Relay Robotics (formerly Savioke) and Aethon (TUG, part of Omnicell). Broad incumbents are Stryker (Mako / hospital equipment) and Omnicell (parent of Aethon). Emerging players are Locus Robotics and Mobile Industrial Robots (MiR).

Does Sphaira have an API?

No public API is recorded for Sphaira.

What industry is Sphaira in?

Its primary akta.pro industry code is HLAHAMAE, Patient Lifts, Transfer & Safe Handling Equipment (Hoists, Slings, Transfer Boards). Its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals